Literature DB >> 14632760

Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa.

R Ciccocioppo1, A Di Sabatino, C Ara, F Biagi, M Perilli, G Amicosante, M G Cifone, G R Corazza.   

Abstract

Tissue transglutaminase (tTG) seems to be the target self-antigen for endomysial antibodies in coeliac disease (CD) and to catalyse the critical deamidation of gliadin which strengthens its recognition by HLA-restricted gut-derived T cells. To date, it has not been demonstrated whether gliadin is cross-linked to tTG within the gut wall, a phenomenon known to occur in vitro. We therefore investigated the putative presence of tTG and gliadin complexes directly in duodenal mucosa. The immunoprecipitation and Western blotting experiments were performed on mucosal biopsies obtained from untreated, treated CD patients and biopsied controls, by using either anti-tTG or anti-gliadin antibodies, in both denaturating/reducing or nondenaturating/nonreducing conditions. A subset of experiments was performed by using anti-tTG antibodies purified by affinity chromatography from sera of untreated coeliac patients. The localization of tTG and gliadin was studied by immunofluorescence at confocal laser microscopy on seriate sections of diseased and normal duodenal mucosa by using the same antibodies of the coimmunoprecipitation section. The amounts of tTG and gliadin coimmunoprecipitated with anti-tTG monoclonal antibody in untreated CD mucosa were significantly increased compared to those of the other two groups. When performing the experiments in nondenaturating/nonreducing conditions, a high molecular weight band formed by both molecules, was evidenciated. Also the anti-tTG antibodies purified from patients' sera turned out to be able to coimmunoprecipitate the two molecules. The analysis by confocal microscopy showed that tTG colocalizes with gliadin at the epithelial and subepithelial levels in active CD, and only in the lamina propria of the villi in normal mucosa. Our findings firstly demonstrated that gliadin was directly bound to tTG in duodenal mucosa of coeliacs and controls, and the ability of circulating tTG-autoantibodies to recognize and immunoprecipitate the tTG-gliadin complexes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632760      PMCID: PMC1808891          DOI: 10.1111/j.1365-2249.2003.02326.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.

Authors:  H Quarsten; O Molberg; L Fugger; S N McAdam; L M Sollid
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

2.  Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.

Authors:  O Molberg; S N Mcadam; R Körner; H Quarsten; C Kristiansen; L Madsen; L Fugger; H Scott; O Norén; P Roepstorff; K E Lundin; H Sjöström; L M Sollid
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

Review 3.  Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.

Authors:  P J Utz; P Anderson
Journal:  Arthritis Rheum       Date:  1998-07

4.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

5.  TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells.

Authors:  G S Kuncio; M Tsyganskaya; J Zhu; S L Liu; L Nagy; V Thomazy; P J Davies; M A Zern
Journal:  Am J Physiol       Date:  1998-02

6.  Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies-the antibody trinity of coeliac disease.

Authors:  R J Lock; J E Gilmour; D J Unsworth
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

7.  Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.

Authors:  Y van de Wal; Y Kooy; P van Veelen; S Peña; L Mearin; G Papadopoulos; F Koning
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

8.  Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease.

Authors:  E M Nilsen; F L Jahnsen; K E Lundin; F E Johansen; O Fausa; L M Sollid; J Jahnsen; H Scott; P Brandtzaeg
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

9.  Increase caused by interleukin-6 in promoter activity of guinea pig liver transglutaminase gene.

Authors:  K Ikura; R Shinagawa; N Suto; R Sasaki
Journal:  Biosci Biotechnol Biochem       Date:  1994-08       Impact factor: 2.043

10.  Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease.

Authors:  S E Bruce; I Bjarnason; T J Peters
Journal:  Clin Sci (Lond)       Date:  1985-05       Impact factor: 6.124

View more
  15 in total

Review 1.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

2.  Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.

Authors:  Umberto Volta; Alessandro Granito; Erica Fiorini; Claudia Parisi; Maria Piscaglia; Georgios Pappas; Paolo Muratori; Francesco B Bianchi
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 3.  Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope.

Authors:  Torsten Matthias; Sascha Pfeiffer; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

4.  Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.

Authors:  W Dieterich; B Esslinger; D Trapp; E Hahn; T Huff; W Seilmeier; H Wieser; D Schuppan
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

Review 5.  The immune recognition of gluten in coeliac disease.

Authors:  R Ciccocioppo; A Di Sabatino; G R Corazza
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

6.  Assessment of a Test for the Screening and Diagnosis of Celiac Disease.

Authors:  Brunetta Porcelli; Fabio Ferretti; Carla Vindigni; Lucia Terzuoli
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

Review 7.  Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.

Authors:  Frits Koning; Ranjeny Thomas; Jamie Rossjohn; Rene E Toes
Journal:  Nat Rev Rheumatol       Date:  2015-05-19       Impact factor: 20.543

8.  Deamidation of gliadin peptides in lamina propria: implications for celiac disease.

Authors:  H Skovbjerg; D Anthonsen; E Knudsen; H Sjöström
Journal:  Dig Dis Sci       Date:  2008-08-05       Impact factor: 3.199

9.  Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study.

Authors:  Julia Gorgun; Anna Portyanko; Yuri Marakhouski; Eugeni Cherstvoy
Journal:  Virchows Arch       Date:  2009-09-12       Impact factor: 4.064

10.  Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases.

Authors:  F Ferrara; S Quaglia; I Caputo; C Esposito; M Lepretti; S Pastore; R Giorgi; S Martelossi; G Dal Molin; N Di Toro; A Ventura; T Not
Journal:  Clin Exp Immunol       Date:  2009-11-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.